- Trading pharmaceutical products, medical equipments, tools and chemicals.

- Producing and trading vaccine and medical products.

- Real estate services.

- Financial investment.

- Other under business lience.

- August 26, 2002: American Vietnamese Biotech Incorporation was established by three founders with charter capital of VND15 billion.

- 2003: Constructing its manufactory with the square of 1,500 m2 in Dong Xoai town, Binh Phuoc Province;

- July 2005: The manufactory was appraised and licensed by Medical Ministry;

- August 2005: AMV began producing and trading products;

- 2006: AMV established a distribution network in the Northern, Middle and Southern through agents.

- April 2007: The company raised its charter capital to VND21 billion;

- December 20, 2009: Traded on Hanoi Stock Exchange (HNX);

- June 26, 2017: Charter capital was raised up to VND271,157,500,000;

- January 20, 2020: Increased charter capital to VND379,620,450,000;

- March 22, 2021: Increased charter capital to VND531,486,160,000;

- April 12, 2021: Increased charter capital to VND911,088,610,000;